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How to improve the company's operating performance is one of the focus of 
attention of listed companies. By contractual arrangements, stakeholders form specific 
corporate governance structure. The balances mechanism under the separation of 
ownership and managerial authority can effectively prevent the behaviors of 
damaging the interests of the company's and the shareholders'. It can ensure the 
long-term orderly development of the enterprise. But, what is the influence of 
ownership structure on corporate performance? What is the effective ownership 
structure of the listed companies? Is it yes or not that optimized ownership structure 
can significantly improve the level of corporate performance?  These problems have 
been closely watched. 
The pharmaceutical industry is very important for people's livelihood,economic 
development and social progress. Its industry position is self-evident. However, its 
characteristics of high technology,high risks and high profitability determines that its 
shareholding structure arrangement is different from other industries. Under the 
background of  the capital market reform and constantly improving listed companies' 
governance, the equity structure of some listed companies is still not reasonabl. The 
level of corporate governance is not high. These seriously affect the operating 
performance and steady development. Therefore, it is necessary for deeply studying 
on the relationship for ownership structure and corporate performance of China's 
pharmaceutical listed companies. The study has a great significance for perfecting the 
corporate governance of listed companies, trainning and establishing the modern 
enterprise system, as well as raising the overall level of the pharmaceutical industry 
development. 
Using qualitative and empirical research methods, firstly, the article concludes 
and states ownership structure status and operation status of the pharmaceutical 
industry in our country. Secondly, the article has carried on the qualitative analysis 
combining the relevant theories. Once again, on the basis of qualitative, The article 













 implement an empirical analysis, and puts forward the research conclusions. Finally, 
based on the research conclusion, it recommends some resources to improve 
ownership structure of pharmaceutical listed companies in China, and to improve their 
operating performance. 
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